Over the years Pfizer has faced lawsuits involving some of its most popular drugs. Courts have dismissed thousands of lawsuits against Pfizer….Pfizer set a record for the largest health care fraud settlement and the largest criminal fine of any kind with $2.3 billion in 2009. Nearly 10,000 women filed Prempro breast cancer lawsuits against Pfizer. By 2012 Pfizer settled most of the claims for more than $1 billion. In 2013 Pfizer agreed to pay $55 million to settle criminal charges over its Protonix. 3,000 people filed Chantix lawsuits against Pfizer. They claimed Chantix caused suicidal thoughts and severe psychological disorders. In 2013 the company set aside about $288 million to resolve these cases. More than 7,800 testosterone therapy lawsuits had been filed against manufacturers as of November 2020. Pfizer had reached an agreement with the consumers suing the company in February 2018, ending its role in the massive litigation. The lawsuits say testosterone products caused strokes, blood clots and heart attacks. These Pfizer products included Effexor, Zoloft, Eliquis, Lipitor which cases judges dismissed as also a US Court of Appeals on Lipitor. Lipitor brought in $9.6 billion in revenue in 2011. https://www.drugwatch.com/manufacturers/pfizer/
………………………..............................................................................................
Penalty records against Pfizer: (AG means Attorney-Gen.) 2009 FDA; 2016 DOJ Civil; 2009 Multi-AG; 2008 Multi-AG; 2912 FDA; 2002 DOJ-Civil; 2012 Multi-AG; 2019 IL-AG; 2014 Multi-AG; 2012 SEC; 2018 DOJ-Civil; 2002 Multi-AG; 2013 TX-AG; 2012 DOJ-Criminal; 2011 FDA; 2014 NV-AG; 2010 HI-AG; 2003 Multi-AG; 2012 OR-AG; 2012 ID-AG; 2011 Multi-AG; 2009 private suit-federal; 2008 EPA; 2019 OR-AG; 2014 EPA; 2018 NY-AG; 2013 MA-AG; 2016 EPA; 2005 EPA; 2006 CT-env.; 2010 CT-env.; 2010, 2005, 2004 EPA; 2002 France; 2012, 2009 OSHA; 2012 CA-DPR. https://violationtracker.goodjobsfirst.org/parent/pfizer
……………………………………………………
In 1961 the Justice Department filed criminal antitrust charges against Pfizer, American Cyanamid, Bristol-Myers and top executives of the three companies. Two years later the FTC ruled that the six companies named in its 1958 complaint had indeed conspired to fix prices on tetracycline. Pfizer announced that it would spend up to $205 million to settle the tens of thousands of valve lawsuits that had been filed against it. Even so Pfizer resisted complying with an FDA order that it notify patients of new findings that there was a greater risk of fatal fractures in those who had the valve installed before the age of 50. In 1994 the company agreed to pay $10.75 million to settle Justice Department charges that it lied to regulators in seeking approval for the valves; it also agreed to pay $9 million to monitor valve patients at Veterans Administration hospitals or pay for removal of the device. In 1999 Pfizer pleaded guilty to criminal antitrust charges that its former Food Science Group unit took part in two international price-fixing conspiracies--one involving the food preservative sodium erythorbate and the other the flavor enhancer maltol. Pfizer agreed to pay fines totaling $20 million. In 2004 Pfizer announced that it had reached a $60 million settlement of a class-action suit brought by users of Rezulin, a diabetes medication developed by Warner-Lambert, which had withdrawn it from the market shortly before the company was acquired by Pfizer in 2000. The withdrawal came after scores of patients died from acute liver failure said to be caused by the drug.
In 2004 in the wake of revelations about dangerous side effects of Merck’s painkiller Vioxx, Pfizer agreed to suspend television advertising for a related medication called Celebrex. The following year Pfizer admitted that a 1999 clinical trial found that elderly patients taking Celebrex had a greatly elevated risk of heart problems. In 2005 Pfizer withdrew another painkiller, Bextra, from the market after the FDA mandated a “black box” warning about the cardiovascular and gastrointestinal risks of the medication. In 2008 Pfizer announced that it was setting aside $894 million to settle the lawsuits that had been filed in connection with Bextra and Celebrex. In 2016 the UK's Competition and Markets Authority fined Pfizer the equivalent of $107 million for charging excessive and unfair prices for an epilepsy drug. https://www.corp-research.org/pfizer
……....................................................................................................
No comments:
Post a Comment